T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

about

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

Item

http://www.wikidata.org/entity/Q47217197

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

@en

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

@nl

type

Item

label

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

@en

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

@nl

prefLabel

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

@en

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

@nl

P1476

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

@en

P2093

Carla A Ruckstuhl

http://www.w3.org/2001/XMLSchema#string

Christian Berchtold

http://www.w3.org/2001/XMLSchema#string

Hector C Keun

http://www.w3.org/2001/XMLSchema#string

Michael Hayoz

http://www.w3.org/2001/XMLSchema#string

Paul A Beavis

http://www.w3.org/2001/XMLSchema#string

Shyam Solanki

http://www.w3.org/2001/XMLSchema#string

Tamara Hilmenyuk

http://www.w3.org/2001/XMLSchema#string

P2860

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

The blockade of immune checkpoints in cancer immunotherapy

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Molecular identification of a danger signal that alerts the immune system to dying cells

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

T cell exhaustion

Nivolumab in previously untreated melanoma without BRAF mutation

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

The inflammasome: first line of the immune response to cell stress.

P304

e1365997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1365997

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carsten Riether

Jean-Marc Nuoffer

Adrian F Ochsenbein

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29296517

http://www.w3.org/2001/XMLSchema#string

P932

5739580

http://www.w3.org/2001/XMLSchema#string